Clinical Trial Update: Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Hib-MenCY-TT vaccine to licensed Hib conjugate vaccine assessing safety and immunogenicity; completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease
• Meningococcal Disease

Drugs mentioned

• Hib-MenCY-TT

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 3 | Status: COMPLETED | Results posted: 2012-08-06